Prepare for FDA’s Evolving Inspection Approach

Webinar Summary

Understand what FDA’s inspection shift means for your audit readiness plan

FDA inspections are becoming more risk-based, systems-focused, and data-driven, creating new pressure on quality systems, digital records, risk management, and inspection response teams. In this webinar, Veranex quality and regulatory experts will break down how FDA’s updated inspection approach is shaping expectations across medical device and combination product manufacturers. Attendees will learn where readiness gaps commonly appear, how to prepare for remote, hybrid, and on-site inspections, and how to strengthen inspection readiness before compliance risk becomes a finding.

Who Should Attend

• Quality Assurance & Quality Control Professionals (Managers, Directors, VPs)
• Regulatory Affairs Professionals responsible for FDA submissions and compliance strategy
• Manufacturing & Operations Leaders accountable for GMP compliance
• Internal Auditors and Inspection Readiness Teams
• Quality system, CAPA, supplier quality, and post-market surveillance teams